ホーム > 斉木 臣二/ Saiki, Shinji

斉木 臣二

Saiki, Shinji

医学医療系神経内科学分野 , 教授
Department of Neurology , Professor

  1. 1. A regression analytical model of serum levodopa metabolic profile in Parkinson's disease Akiko Chukyo; Osamu Komori; Motoki Fujimaki; Naoko Kaga (+20 著者) Shinji Saiki
      Heliyon 12: e44615 (2026) Semantic Scholar
  2. 2. Fully automated segmentation of substantia nigra toward longitudinal analysis of Parkinson’s disease Tao Hu; Hayato Itoh; Masahiro Oda; Shinji Saiki (+5 著者) Kensaku Mori
      International Journal of Computer Assisted Radiology and Surgery (2025) Semantic Scholar
  3. 3. Content-consistent adaptation network for substantia nigra segmentation in cross-modalities and -datasets scenarios without retraining Tao Hu; Hayato Itoh; Masahiro Oda; Shinji Saiki (+5 著者) Kensaku Mori
      Medical Imaging 2025: Image Processing 114 (2025) Semantic Scholar
  4. 4. Ubiquilin-2 liquid droplets catalyze α-synuclein fibril formation Tomoki Takei; Yukiko Sasazawa; Daisuke Noshiro; Mitsuhiro Kitagawa (+15 著者) Nobutaka Hattori
      (2025)
  5. 5. Comprehensive data for studying serum exosome microRNA transcriptome in Parkinson’s disease patients Zhiyang Yu; Shinji Saiki; Kenta Shiina; Tatou Iseki (+9 著者) Nobutaka Hattori
      Scientific Data 11: (2024) Semantic Scholar
  6. 6. Clustering lysosomes around the MTOC: a promising strategy for SNCA/alpha-synuclein breakdown leading to parkinson disease treatment Yukiko Sasazawa; Yuki Date; Nobutaka Hattori; Shinji Saiki
      Autophagy 20: 2839 (2024) Semantic Scholar
  7. 7. Preliminary study of substantia nigra analysis by tensorial feature extraction Hayato Itoh; Masahiro Oda; Shinji Saiki; Koji Kamagata (+4 著者) Kensaku Mori
      International Journal of Computer Assisted Radiology and Surgery (2024) Semantic Scholar
  8. 8. Novel autophagy inducers by accelerating lysosomal clustering against Parkinson's disease Yuki Date; Yukiko Sasazawa; Mitsuhiro Kitagawa; Kentaro Gejima (+6 著者) Shinji Saiki
      eLife 13: (2024) Semantic Scholar
  9. 9. Safinamide as adjunctive therapy to levodopa monotherapy for patients with Parkinson's disease with wearing-off: The Japanese observational J-SILVER study. Noriko Nishikawa; Taku Hatano; Kenya Nishioka; Shin-Ichi Ueno (+10 著者) Nobutaka Hattori
      Journal of the neurological sciences 461: 123051 (2024) Semantic Scholar
  10. 10. Targeting the autophagy-NAD axis protects against cell death in Niemann-Pick type C1 disease models Tetsushi Kataura; Lucia Sedlackova; Congxin Sun; Gamze Kocak (+13 著者) Viktor I. Korolchuk
      Cell Death & Disease 15: (2024) Semantic Scholar
  11. 11. Boosting substantia nigra segmentation from T2 weighted MRI via test-time normalization and distance-reweighted loss Tao Hu; Hayato Itoh; Masahiro Oda; Shinji Saiki (+5 著者) Kensaku Mori
      Medical Imaging 2024: Computer-Aided Diagnosis (2024) Semantic Scholar
  12. 12. Free-water diffusion magnetic resonance imaging under selegiline treatment in Parkinson's disease. Haruka Takeshige-Amano; Taku Hatano; Koji Kamagata; Christina Andica (+11 著者) Nobutaka Hattori
      Journal of the neurological sciences 457: 122883 (2024) Semantic Scholar
  13. 13. Free-water diffusion magnetic resonance imaging under selegiline treatment in Parkinson's disease Haruka Takeshige-Amano; Taku Hatano; Koji Kamagata; Christina Andica (+11 著者) Nobutaka Hattori
      Journal of the Neurological Sciences 457: (2024) Semantic Scholar
  14. 14. Extracellular vesicles contain filamentous alpha-synuclein and facilitate the propagation of Parkinson's pathology. Yuta Ishiguro; Taiji Tsunnemi; Tomoyo Shimada; Asako Yoroisaka (+5 著者) Nobutaka Hattori
      Biochemical and biophysical research communications 703: 149620 (2024) Semantic Scholar
  15. 15. Efficacy and Safety of Elobixibat in Parkinson's Disease with Chronic Constipation: CONST-PD Study. Taku Hatano; Genko Oyama; Yasushi Shimo; Kotaro Ogaki (+26 著者) Nobutaka Hattori
      Movement disorders clinical practice (2024) Semantic Scholar
  16. 16. Wearing off現象が認められるパーキンソン病患者を対象としたレボドパ単剤治療へのサフィナミド併用療法に関する観察研究(J-SILVER study) 西川 典子; 波田野 琢; 上野 真一; 斉木 臣二 (+11 著者) 服部 信孝
      日本神経精神薬理学会年会プログラム・抄録集 53回: 159 (2023)
  17. 17. 特発性パーキンソン病由来iPS細胞の表現型に基づく分類とその応用(Phenotype-based classification of idiopathic Parkinson's disease derived iPSCs and its application) Yamaguchi Akihiro; Ishikawa Kei-ichi; Saiki Shinji; Hattori NobutakaAkamatsu Wado
      臨床神経学 63: S331 (2023)
  18. 18. パーキンソン病の運動症状とMRIパラメータに対するラサギリンの影響(Effects of rasagiline on motor symptoms and MRI parameters in Parkinson's disease) Saiki Shinji; Shiina Kenta; Iseki Tatou; Yamashita Yuri (+13 著者) Hattori Nobutaka
      臨床神経学 63: S229 (2023)
  19. 19. JNK‐interacting protein 4 is a central molecule for lysosomal retrograde trafficking Yukiko Sasazawa; Nobutaka Hattori; Shinji Saiki
      BioEssays (2023) Semantic Scholar
  20. 20. パーキンソン病初期における甲状腺-肝連関による全身性代謝変化 宮本 健吾; 斉木 臣二; 松本 拡高; 鈴木 絢未 (+10 著者) 服部 信孝
      パーキンソン病・運動障害疾患コングレスプログラム・抄録集 17回: 91 (2023)
1 2 3 … 7

書籍等出版物情報はまだありません。

講演・口頭発表情報はまだありません。

 211 total views